Stephen Mandel
Lone Pine Capital
Stephen Mandel Forma Therapeutics Holdings Inc stake
total: 304
Lone Pine Capital FMTX trades
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2020 Q4
- Held for:
- 4 quarters
- Latest activity:
- 2021 Q4
According to 2026 Q2 report, Stephen Mandel doesn't hold any Forma Therapeutics Holdings Inc (FMTX) shares. To date, the estimated cost basis is nearly $34.9 for "buy" trades and estimated average "sell" price is $23.19. Lone Pine Capital first purchased FMTX in 2020 Q4, initially acquiring 800,000 shares. Since the initial investment in Forma Therapeutics Holdings Inc (FMTX), Lone Pine Capital has made 1 more transaction.
When did Stephen Mandel sell Forma Therapeutics Holdings Inc (FMTX)?
Stephen Mandel sold off the entire Forma Therapeutics Holdings Inc (FMTX) position in 2021 Q4.
When did Stephen Mandel buy Forma Therapeutics Holdings Inc (FMTX)?
Stephen Mandel first invested in Forma Therapeutics Holdings Inc (FMTX) in 2020 Q4 at the reported quarter-end price of $34.90 per share.
What's the cost basis of Lone Pine Capital's FMTX stake?
The estimated cost basis for Forma Therapeutics Holdings Inc (FMTX) stake is around $34.90 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $34.90
- Weighted AVG sell price:
- $23.19
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.